GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Accumulated Depreciation

FBLG (FibroBiologics) Accumulated Depreciation : $-0.16 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

FibroBiologics's quarterly accumulated depreciation increased from Mar. 2024 ($-0.08 Mil) to Jun. 2024 ($-0.12 Mil) and increased from Jun. 2024 ($-0.12 Mil) to Sep. 2024 ($-0.16 Mil).

FibroBiologics's annual accumulated depreciation stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($-0.05 Mil).


FibroBiologics Accumulated Depreciation Historical Data

The historical data trend for FibroBiologics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Accumulated Depreciation Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Accumulated Depreciation
- - -0.05

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -0.05 -0.08 -0.12 -0.16

FibroBiologics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


FibroBiologics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.